Hot Features
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to de... Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company’s IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs. It focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Houston, Texas. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.68 | -20.2898550725 | 8.28 | 9.57 | 6.6 | 25515 | 8.06076378 | CS |
| 4 | 0.85 | 14.7826086957 | 5.75 | 9.57 | 4.3201 | 16074 | 6.90524383 | CS |
| 12 | -1 | -13.1578947368 | 7.6 | 9.57 | 4.3201 | 19777 | 6.40050817 | CS |
| 26 | 5.8254 | 752.052672347 | 0.7746 | 9.57 | 0.53191 | 1229786 | 1.2673091 | CS |
| 52 | 5.8254 | 752.052672347 | 0.7746 | 9.57 | 0.53191 | 1229786 | 1.2673091 | CS |
| 156 | 5.8254 | 752.052672347 | 0.7746 | 9.57 | 0.53191 | 1229786 | 1.2673091 | CS |
| 260 | 5.8254 | 752.052672347 | 0.7746 | 9.57 | 0.53191 | 1229786 | 1.2673091 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.